FaibaLite - Reduce Weight, One Bite at a Time (NCT07045766) | Clinical Trial Compass
WithdrawnNot Applicable
FaibaLite - Reduce Weight, One Bite at a Time
Stopped: Competing study and lack of resource
0Started 2026-01-01
Plain-language summary
This study aims to evaluate the suitability of a fiber-enriched chewing gum as a practical and accessible approach to support healthy body weight management.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Written Informed Consent
* Healthy adults aged 18 to 65 years (inclusive), as determined by the investigator
* BMI of 23 to 40 kg/m2 (inclusive)
* Living in Switzerland
* Ability and willingness to follow the study protocol (e.g., cognitive capacity for compliance, gum chewing)
* Access and willingness to use an electronic device (e.g., mobile phone, computer or tablet)
* Access to a scale to self-report weight
Exclusion Criteria:
* Current weight loss therapy with Glucagon-like Peptide 1 (GLP-1) agonists or other non-prescription products (at investigator's discretion)
* Treatment with a GLP-1 agonist within the past 2 months
* Initiation/Discontinuation of nicotine product use (\>1 nicotine product per day, e.g., (e-)cigarette, gum) within the last 2 months (at investigator's discretion)
* Significant change in medication within the last 2 months (at investigator's discretion)
* Unable to chew gum 3 times daily (e.g. due to dental issues, at investigator's discretion)
What they're measuring
1
Composite primary endpoint: Feasibility of conducting the study based on participant adherence rate, user acceptance score, and dropout rate